Chames P - Search Results

1

A Bispecific Antibody-Based Approach for Targeting Mesothelin in Triple Negative Breast Cancer.

Del Bano J, Florès-Florès R, Josselin E, Goubard A, Ganier L, Castellano R, Chames P, Baty D, Kerfelec B. Del Bano J, et al. Among authors: chames p. Front Immunol. 2019 Jul 10;10:1593. doi: 10.3389/fimmu.2019.01593. eCollection 2019. Front Immunol. 2019. PMID: 31354732 Free PMC article.

2

Polymerase chain reaction-based site-directed mutagenesis using magnetic beads.

Fieschi J, Niccoli P, Camilla C, Chames P, Chartier M, Baty D. Fieschi J, et al. Among authors: chames p. Anal Biochem. 1996 Feb 15;234(2):210-4. doi: 10.1006/abio.1996.0074. Anal Biochem. 1996. PMID: 8714600

3

Production of a soluble and active MBP-scFv fusion: favorable effect of the leaky tolR strain.

Chames P, Fieschi J, Baty D. Chames P, et al. FEBS Lett. 1997 Mar 24;405(2):224-8. doi: 10.1016/s0014-5793(97)00194-4. FEBS Lett. 1997. PMID: 9089295 Free article.

4

Intracellular immunization of prokaryotic cells against a bacteriotoxin.

Chames P, Fieschi J, Baty D, Duché D. Chames P, et al. J Bacteriol. 1998 Feb;180(3):514-8. doi: 10.1128/JB.180.3.514-518.1998. J Bacteriol. 1998. PMID: 9457852 Free PMC article.

5

Engineering of an anti-steroid antibody: amino acid substitutions change antibody fine specificity from cortisol to estradiol.

Chames P, Baty D. Chames P, et al. Clin Chem Lab Med. 1998 Jun;36(6):355-9. doi: 10.1515/CCLM.1998.060. Clin Chem Lab Med. 1998. PMID: 9711421

6

Improving the affinity and the fine specificity of an anti-cortisol antibody by parsimonious mutagenesis and phage display.

Chames P, Coulon S, Baty D. Chames P, et al. J Immunol. 1998 Nov 15;161(10):5421-9. J Immunol. 1998. PMID: 9820517

7

Antibody engineering and its applications in tumor targeting and intracellular immunization.

Chames P, Baty D. Chames P, et al. FEMS Microbiol Lett. 2000 Aug 1;189(1):1-8. doi: 10.1111/j.1574-6968.2000.tb09197.x. FEMS Microbiol Lett. 2000. PMID: 10913857 Review.

8

Isolation and characterization of anti-FcgammaRIII (CD16) llama single-domain antibodies that activate natural killer cells.

Behar G, Sibéril S, Groulet A, Chames P, Pugnière M, Boix C, Sautès-Fridman C, Teillaud JL, Baty D. Behar G, et al. Among authors: chames p. Protein Eng Des Sel. 2008 Jan;21(1):1-10. doi: 10.1093/protein/gzm064. Epub 2007 Dec 11. Protein Eng Des Sel. 2008. PMID: 18073223

9

Bispecific antibodies for cancer therapy.

Chames P, Baty D. Chames P, et al. Curr Opin Drug Discov Devel. 2009 Mar;12(2):276-83. Curr Opin Drug Discov Devel. 2009. PMID: 19333873 Review.

10

Therapeutic antibodies: successes, limitations and hopes for the future.

Chames P, Van Regenmortel M, Weiss E, Baty D. Chames P, et al. Br J Pharmacol. 2009 May;157(2):220-33. doi: 10.1111/j.1476-5381.2009.00190.x. Br J Pharmacol. 2009. PMID: 19459844 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters